Original article
Interaction of liposomes with Kupffer cells in vitro

https://doi.org/10.1016/0014-4827(84)90711-0Get rights and content

Abstract

We investigated the interaction of liposomes with rat Kupffer cells in monolayer maintenance culture. The liposomes (large unilamellar vesicles, LUV) were composed of 14C-labelled phosphatidylcholine, cholesterol and phosphatidylserine (molar ratio 4 : 5 : 1) and contained either 3H-labelled inulin or 125I-labelled bovine serum albumin as a non-degradable or a degradable aqueous space marker, respectively. After 2–3 days in culture the cells exhibited optimal uptake capacity.

The uptake process showed saturation kinetics, maximal uptake values amounting to 2 nmol of total liposomal lipid/h/106 cells. This is equivalent to 1500 vesicles per cell. The presence of fetal calf serum (FCS) during incubation increased uptake nearly two-fold, whereas freshly isolated rat serum had no effect. The binding of the liposomes to the cells caused partial release of liposomal contents (about 15–20%) both at 4°C and at 37°C. In the presence of metabolic inhibitors the uptake at 37°C was reduced to about 20% of the control values. Inulin and lipid label became cell-associated at similar rates and extents, whereas the association of albumin label gradually decreased after attaining a maximum at relatively low values. When, after 1 h incubation, the liposomes were removed continued incubation for another 2 h in absence of liposomes led to an approx. 30% release of cell-associated lipid label into the medium in water-soluble form. Under identical conditions as much as 90% of the cell-associated albumin label was released in acid-soluble form. Contrarily, the inulin label remained firmly cell-associated under these conditions. From these results we conclude that Kupffer cells in monolayer culture take up liposomes primarily by way of an adsorptive endocytic mechanism. This conclusion was confirmed by morphological observations on cells incubated with liposomes containing fluorescein isothiocyanate (FITC) dextran or horseradish peroxidase as markers for fluorescence microscopy and electron microscopy, respectively.

References (41)

  • F Roerdink et al.

    Biochim biophys acta

    (1981)
  • D Hoekstra et al.

    Biochim biophys acta

    (1978)
  • D Hoekstra et al.

    Biochim biophys acta

    (1979)
  • D Hoekstra et al.

    Biochim biophys acta

    (1980)
  • W Stoffel
  • FC Szoka et al.

    Biochim biophys acta

    (1980)
  • DL Knook et al.

    Exp cell res

    (1976)
  • J Damen et al.

    Biochim biophys acta

    (1981)
  • OH Lowry et al.

    J biol chem

    (1951)
  • BN Ames et al.

    J biol chem

    (1960)
  • L Ose et al.

    Exp cell res

    (1980)
  • E Wisse

    J ultrastruct res

    (1974)
  • S Bigelow et al.

    Cell

    (1981)
  • AC Munthe-Kaas

    Exp cell res

    (1976)
  • E Mayhew et al.

    Biochem pharmacol

    (1980)
  • VP Torchilin et al.

    FEBS lett

    (1980)
  • J Freise et al.

    Exp cell res

    (1980)
  • G Gregoriadis et al.

    Eur j biochem

    (1974)
  • YE Rahman et al.
  • FH Roerdink et al.
  • Cited by (97)

    • Liposomal delivery of natural product: A promising approach in health research

      2019, Trends in Food Science and Technology
      Citation Excerpt :

      Conventional liposomes, such as neutral and anionic liposome are internalized into the cell via endocytosis process and generates cellular endocytes. This endocytes subsequently release the liposomal content into the cytoplasm through the acidification of endosomes followed by fusion with lysosomal enzyme and low pH (Fig. 3) (Dijkstra et al., 1984). The pH-sensitive liposomes are internalized more efficiently than non-pH-sensitive liposomes due to the presence of pH-sensitive molecules, such as phosphatidylethanolamine, oleic acid, linoleic acid etc.

    • Nano design of extracellular matrix for tissue engineering

      2019, Nanoarchitectonics in Biomedicine
    • Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy

      2017, Journal of Controlled Release
      Citation Excerpt :

      It should be noted, however, that although the efficiency of targeting could improve cellular uptake, additional modifications may be required to ensure the effective release of the drug within the cytoplasm. Liposomal formulations can be degraded by lysozymes within the cellular matrix before the release of the liposome's therapeutic contents to the cytoplasm [47]. In order to increase the probability that a drug is released into the cytoplasm prior to its degradation, the formulation should be quickly destabilized after endocytosis [48].

    • Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development

      2008, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      However, the retention of drug is likely to be both different and important in various tissues, including both the site of disease and potential sites of toxicity, where interactions with cells and various tissue environments may play a significant role in determining how rapid a particular drug is released from its liposomal carrier. For example, tumor-residing, spleenic, or liver macrophages can phagocytose liposomes, degrade the carriers, and release the drug,243-245 thus substantially increasing the bioavailability of the drug in tissues compared to what is observed in the blood. For a stable liposomal drug formulation like pegylated liposomal doxorubicin, where one-half of the drug is released at more than 90 h,120, 156 the majority of doxorubicin release does not occur until after accumulation in the tumor.

    View all citing articles on Scopus

    These investigations were carried out under the auspices of the Netherlands Foundation for Medical Research (FUNGO) with financial support from the Netherlands Organization for the Advancement of Pure Research (ZWO).

    View full text